<\/p>\n
Admenta<\/strong> er en oral tablet fra Sun Pharma, der indeholder memantine 5 mg<\/strong> \u2014 et uncompetitive NMDA receptor antagonist<\/strong> anvendes til den symptomatiske behandling af moderat til sv\u00e6r Alzheimers sygdom<\/strong>. Memantine is ikke<\/strong> indicated for mild Alzheimer's. Slow upward titration over 4 weeks: 5 mg week 1, 10 mg week 2 (5 mg twice daily), 15 mg week 3, 20 mg week 4 onwards (10 mg twice daily)<\/strong>. Generally well tolerated — main side effects are dizziness, headache, constipation and confusion. Reduce dose if eGFR < 30 mL\/min<\/strong>. Often combined with donepezil in moderate-to-severe disease for additive cognitive benefit.<\/p>\n<\/div>\n \ud83d\udce6 Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n Vores generiske medicin kommer fra WHO-GMP certificerede producenter og sendes verdensomsp\u00e6ndende i diskret, neutral emballage \u2014 ingen medicinnavn p\u00e5 pakkens ydre. Kortbetalinger h\u00e5ndteres af en reguleret processor (kontoudtogsbeskrivelser inkluderer en reguleret betalingsprocessor \u2014 aldrig \u201cMedsBase\u201d eller medicinnavn). Crypto og SEPA bankoverf\u00f8rsel accepteres ogs\u00e5. Hver ordre er d\u00e6kket af vores Reshipment Assurance Policy.<\/p>\n Admenta is an oral tablet from Sun Pharma containing memantine hydrochloride 5 mg<\/strong>. Memantine is a low-affinity, voltage-dependent, uncompetitive antagonist of the N-methyl-D-aspartate (NMDA) glutamate receptor<\/strong>. It is mechanistically distinct from the cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and works through the second major pathway implicated in Alzheimer's disease — glutamate excitotoxicity.<\/p>\n Admenta from Sun Pharma is a 5 mg memantine tablet — the strength used during the mandatory 4-week up-titration to the 20 mg\/day maintenance dose. Maintenance dosing is two 5 mg tablets twice daily (4 tablets total per day). Memantine is licensed only for moderat til sv\u00e6r Alzheimers sygdom<\/strong> — not mild. It is the standard add-on to a cholinesterase inhibitor (typically donepezil) when patients progress past the mild stage, and produces additive cognitive and functional benefit with minimal increase in side effects.<\/p>\n Alzheimer's disease causes chronic excessive glutamate signalling at NMDA receptors — a process called glutamate excitotoxicity<\/strong>. Constant low-level NMDA activation damages neurons and disrupts the signal-to-noise ratio that the brain needs for learning and memory. Memantine addresses this through a unique mechanism:<\/p>\n Inds\u00e6ttelse af kognitiv forbedring: synlig ved 4\u201312 uger<\/strong> after reaching the maintenance 20 mg\/day dose; peak benefit at 6 months.<\/p>\n Admenta is ikke<\/strong> indikeret til: mild Alzheimer's disease<\/strong> (cholinesterase inhibitors are first-line at this stage), mild cognitive impairment without dementia, frontotemporal dementia, or as a cognitive enhancer in healthy adults.<\/p>\n Admenta comes at 5 mg<\/strong> tablets. The titration schedule is mandatory — jumping straight to 20 mg\/day causes intolerable confusion and dizziness in most patients.<\/p>\n Standard 4-week titration:<\/strong><\/p>\n Common (worst during titration, settle once on maintenance):<\/strong><\/p>\n Mindre almindelige:<\/strong><\/p>\n Rare but seek medical review:<\/strong><\/p>\nHvorfor bestille fra MedsBase<\/h3>\n
What Is Admenta?<\/h2>\n
How Does Admenta Work?<\/h2>\n
\n
\u2014 det forst\u00e6rker den normale fysiologiske respons snarere end at udl\u00f8se en kunstigt.<\/h2>\n
\n
Admenta Dosage and How to Take — SLOW TITRATION<\/h2>\n
\n
How to Take Admenta Properly<\/h3>\n
\n
Side Effects of Admenta<\/h2>\n
\n
\n
\n
Advarsler og forholdsregler<\/h2>\n
\n
Contraindications — Who Should NOT Take Admenta<\/h2>\n
\n
L\u00e6gemiddelinteraktioner<\/h2>\n